Viewing Study NCT06048133


Ignite Creation Date: 2025-12-25 @ 2:44 AM
Ignite Modification Date: 2025-12-26 @ 1:24 AM
Study NCT ID: NCT06048133
Status: RECRUITING
Last Update Posted: 2025-05-04
First Post: 2023-09-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)
Sponsor: Nataliya Uboha
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module